Designing Longevity
Skip to main content
Testosterone (TRT)

Maximus

Fertility-preserving oral TRT with enclomiphene; published clinical study, but F rating with unanswered complaints

Edited by Designing Longevity Editorial · earlier profile checked May 1, 2026

3.1

of 5 · earlier editorial rating
May 1, 2026

The editorial rating reflects checks from May 1, 2026. Program terms below have separate source dates. Neither is a medical or pharmacy inspection.

No financial relationship with Maximus. Editorial inclusion only.

Visit Maximus

Program costs and payment terms

Current program terms need a fresh check. Get a written price and billing quote directly before paying.

Membership
Current membership price needs a fresh check.
Insurance
Insurance terms need a fresh check; confirm directly before paying.

Designing Longevity is a founder-led editorial publication. Our content is not medically reviewed.

The full profile and rubric were last checked May 1, 2026. Current commercial terms above have their own check date; they do not refresh earlier ratings or clinical claims.

Earlier editorial take

Earlier review: best for

  • Users specifically wanting fertility-preserving TRT

    The Oral T + Enclomiphene protocol preserves LH/FSH within normal ranges, unlike traditional injectable TRT which suppresses both. For younger men, men actively trying to conceive, or men who want to preserve testicular function while raising testosterone levels, this is the differentiated option in our cohort.

  • Users who weight published-clinical-study evidence

    Maximus is the only hormone-TRT provider in our cohort with publicly-documented clinical study results on its specific protocol. For users who specifically want clinical-evidence transparency from their telehealth provider, this is a meaningful differentiator.

Look elsewhere if

  • Users on traditional injectable TRT

    Maximus's protocol is oral testosterone + enclomiphene, not the standard intramuscular or subcutaneous testosterone protocol most TRT users are familiar with. Hone Health, Defy Medical, or Marek Health are the cohort options for traditional injectable TRT.

  • Users who weight BBB complaint posture at all

    The F driven by unanswered complaints is a meaningful operational signal. If responsive customer service and clean cancellation flow matter to you, this is a real concern. Hone Health (BBB Accredited) is the cohort default for users who weight BBB signals.

Our take

Maximus is the only TRT provider in our cohort with a publicly-documented clinical study on its specific protocol (4x total testosterone and 5x free testosterone with LH/FSH preserved on the Oral T + Enclomiphene approach), which is a meaningful clinical-transparency advantage. The fertility-preservation angle is also genuinely differentiating for younger men or those concerned about fertility on traditional injectable TRT. Honest counterweights are real and stack: F rating driven by unanswered complaints (structurally similar to Henry Meds's failure mode), small sample relative to cohort competitors, and a broader -medication footprint that extends beyond TRT into and other categories. Choose Maximus if fertility-preserving oral TRT is specifically the binding need and you've read the BBB complaint pattern and decided you're comfortable with the operational risk; otherwise Hone Health remains the cleaner default for hormone-TRT.

Pros

  • Only TRT provider in our cohort with a publicly-documented clinical study on its specific protocol
  • Fertility-preserving Oral T + Enclomiphene protocol (LH/FSH preserved within normal ranges)
  • 4.4-4.6/5 with no fraud notice (smaller sample than cohort leaders)
  • No ; no active manufacturer lawsuits
  • Published protocol whitepapers and study results on the public site

Cons

  • Two profiles for the same operating company (Maximus Tribe and Maximus Health, Inc.) in unusual vitamins-and-supplements category
  • Small sample (200-260) relative to Hone Health (10,000+)
  • Broader footprint ( weight loss, oxytocin calming cream, etc.) adds vendor exposure
  • ExcelMale forum threads document recurring communication friction with the platform

Pricing

Current pricing needs a fresh check.

Turnaround

Initial labs + clinician review before Rx; same-week turnaround

States served

All 50

Earlier full review checked

May 1, 2026

What Maximus says, and what we found

The provider's own marketing claims, paired with our verdict. Color-coded so you can scan: green for verified, amber for stated-but-unconfirmed, violet for context.

VerifiedCare model

Confirmed against the public study review page. The published-clinical-study transparency is genuinely differentiated in our hormone-TRT cohort.

Maximus Tribe published clinical study results showing 4x total testosterone and 5x free testosterone with LH/FSH preserved on the Oral T + Enclomiphene protocol.

Maximus Tribe clinical study review · captured May 1, 2026 · source

Earlier rubric breakdown

How the earlier rating was scored

Licensure

20% weight
3.5/5

License and enforcement records checked at the profile verification date.

No on Maximus Health, Inc. or Maximus Tribe verified at capture date. No active manufacturer lawsuits.

Evidence checked in the earlier review (3)

  • No FDA warning letter on Maximus / Maximus Tribe / Maximus Health

    Federal database

    Checked May 1, 2026 · source

  • Maximus Tribe BBB profile (Santa Monica, CA)

    Business filing

    Vitamins-and-supplements category in Santa Monica. The unusual category placement (vs telemedicine or clinic) is itself a softer signal about how the company has positioned itself with the .

    Checked May 1, 2026 · source

  • Maximus Health, Inc. BBB profile (Santa Monica, CA)

    Business filing

    Separate profile for the operating-entity name, also in Santa Monica, also vitamins-and-supplements category. The dual-profile setup is unusual; consolidates vs splits depending on how readers search.

    Checked May 1, 2026 · source

Accreditation

20% weight
1.5/5

Accreditation records checked at the profile verification date.

F rating, NOT Accredited. The F is driven by unanswered complaints, structurally similar to Henry Meds's failure mode in our cohort. Multiple BBB complaints document repeat charges without medication delivery, refused refunds, and unanswered cancellation requests. not independently confirmable on a public registry. Tied with Henry Meds for the worst accreditation posture across our entire marketplace cohort.

Evidence checked in the earlier review (1)

  • LegitScript Healthcare Merchant Certification

    Accreditation

    Not independently confirmable on a public registry. Maximus advertises through standard channels which generally requires , but we cannot point to a public source.

    Checked May 1, 2026

Transparency

20% weight
4.0/5

Published testing, sourcing, and formulation information.

Published clinical study results on the oral testosterone + enclomiphene protocol (4x total testosterone increase, 5x free testosterone, with LH/FSH preserved within normal ranges). Protocol whitepapers public. The depth of clinical-evidence transparency is meaningfully stronger than the typical TRT telehealth competitor; Maximus is the only TRT provider in our cohort with a publicly-documented clinical study on its specific protocol.

Evidence checked in the earlier review (2)

  • Published clinical study on Oral T + Enclomiphene protocol

    Care-model transparency

    Clinical study results documenting 4x total testosterone and 5x free testosterone increases with the Oral TRT + Enclomiphene protocol. Average peak total T 1327 ng/dL and peak free T 38.3 ng/dL (administered with 30g fat). LH/FSH preserved within normal ranges, distinguishing the protocol from traditional injectable TRT which suppresses both.

    Checked May 1, 2026 · source

  • Protocol whitepaper published

    Care-model transparency

    Checked May 1, 2026

Product quality

15% weight
3.5/5

Published testing, recall, and supply-chain information.

This earlier product-quality score has not been refreshed. The commercial update does not recheck manufacturing, sourcing or clinical care.

Evidence checked in the earlier review (2)

  • Oral testosterone + enclomiphene protocol with clinical study backing

    Care model

    The clinical study documenting 4x total T and 5x free T increases with LH/FSH preserved is the strongest care-model evidence in our hormone-TRT cohort. The protocol is structurally different from injectable TRT and is the central reason fertility-conscious users choose Maximus.

    Checked May 1, 2026 · source

  • No FDA recalls on Maximus-distributed product

    Recall history

    Checked May 1, 2026 · source

Pricing

15% weight
4.0/5

Value within the category, no surprise fees, refund policy.

Current pricing needs a fresh check.

Customer service

10% weight
2.0/5

Refund policy, support quality, complaint history.

4.4-4.6/5 across roughly 200-260 reviews depending on which Trustpilot mirror you reach (relatively small sample for a cohort that includes Hone's 10,000+ reviews). No suspected-fraudulent-review notice. The structural failure mode mirrors Henry Meds's picture in the cohort.

Evidence checked in the earlier review (2)

  • Trustpilot 4.4-4.6/5 across roughly 200-260 reviews

    External review

    Smaller sample than Hone (10K+) or Defy (3.8K). No fraud notice on the page at capture date. Positives concentrate on protocol effectiveness (testosterone-level results documented in user posts) and customer service responsiveness (when contact succeeds).

    Checked May 1, 2026 · source

  • ExcelMale community discussion

    Forum commentary

    ExcelMale (the largest TRT-focused community forum) has multiple multi-page threads on Maximus protocols. Recurring themes: testosterone-level results consistent with the published clinical study, but communication friction with the platform for some users.

    Checked May 1, 2026 · source

Public reviews

What we found across third-party review platforms. These are external sentiment signals, not our scoring inputs.

Trustpilot

4.4-4.6/5 across roughly 200-260 reviews depending on which mirror you reach. No fraud notice on the page at capture date. Smaller sample than cohort leaders. Positives concentrate on protocol effectiveness (testosterone-level results matching the published clinical study) and educational resources. Negatives concentrate on shipment delays, communication friction, and concerns about the company moderating dissenting views on its community forum.

Captured May 1, 2026Source

Better Business Bureau

NOT Accredited. F rating driven by unanswered complaints. Vitamins-and-supplements category in Santa Monica. Documented complaint themes: repeat charges without medication delivery, refund refusals after cancellation, doctor-visit no-shows with refused refunds, difficulty reaching a real person.

Captured May 1, 2026Source

ExcelMale forum

ExcelMale (the largest TRT-focused community forum) has multi-page threads on Maximus protocols. Recurring themes: testosterone-level results consistent with the published clinical study (positive feedback on protocol effectiveness), but communication friction with the platform and difficulty reaching support.

Captured May 1, 2026Source

What to expect

  1. 1

    Initial labs

    5-10 days

    Maximus orders baseline labs (testosterone, estradiol, hematocrit, comprehensive metabolic panel). Results typically back in 5-10 days.

  2. 2

    Clinician review and Rx

    Same-week turnaround

    Board-certified physician reviews labs and protocol. If TRT is appropriate, prescription is issued and shipped from a partner compounding pharmacy. Cold-chain shipping for any injectable formulations.

Accreditations

State pharmacy/clinic license

Verified · May 1, 2026

LegitScript Certified

Unverified · May 1, 2026 · source

Frequently asked

What's the difference between Maximus's protocol and traditional TRT?

Traditional TRT is injectable testosterone (intramuscular or subcutaneous) which raises testosterone levels but suppresses LH and FSH (the hormones that drive your body's own testosterone production and testicular function). Maximus's flagship protocol is oral testosterone plus enclomiphene, designed to raise testosterone levels while preserving LH and FSH within normal ranges. The fertility-preservation angle is the central differentiator. The enclomiphene-only protocol uses just the SERM without supplemental testosterone, which raises your body's own testosterone production over time rather than replacing it.

Is the Maximus clinical study legitimate?

The study and results are published on the company's public site. The headline findings are 4x total testosterone increase, 5x free testosterone increase, with LH/FSH preserved within normal ranges, and average peak total T of 1327 ng/dL when administered with 30g fat. Maximus is the only TRT provider in our cohort with a publicly-documented clinical study on its specific protocol, which is a meaningful clinical-transparency advantage. The study was conducted by the company on its own protocol, so it is internal evidence rather than independent academic research; weight it accordingly.

Update history

Every meaningful change to this profile, with a date stamp. We don't silently re-score.

  1. May 1, 2026

    Initial published profile. Sources HEAD-checked at publish time. Score (3.1) reflects the clinical-transparency advantage (only published protocol study in our hormone-TRT cohort, fertility-preservation differentiator) weighed against the F rating with unanswered complaints, small sample, and broader footprint extending beyond TRT.

Edited by Designing Longevity Editorial. Earlier profile checked May 1, 2026.

Spot something out of date or wrong? Let us know and we'll re-check.

Back to all providers